For the Inventor, By the Inventor

Enter inventor name

Indianapolis, IN, United States of America

Freddie Craig Stevens

This inventor holds 12 USPTO granted patents, plus 1 CIPO patent and 3 EPO patents. Top assignee: Eli Lilly and Company. Active years: 2004-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Freddie Craig Stevens. Retrieved from https://idiyas.com/inventor/freddie-craig-stevens

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12

% Patents Active = 16.7

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 2)

Average Co-Inventor Count = 5.6

ph-index = 3

Forward Citations = 19(Granted Patents)

Company Filing History:

12 out of 4,509

Eli Lilly and Company

Years Active: 2004-2026

Loading Chart...

Loading Chart...

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12516063 - Substituted 7-(methylamino)pyrazolo[1,5-a]pyrimidine-3-carboxamide derivatives for treating autoimmune diseases (2026-01-06),

2. 9469632 - [object Object] (2016-10-18),

3. 7951826 - Pyrrolidine derivatives as histamine H3 receptor antagonists (2011-05-31),

4. 7846950 - Histamine H3 receptor inhibitors, preparation and therapeutic uses (2010-12-07),

5. 7696234 - Histamine H3 receptor agents, preparation and therapeutic uses (2010-04-13),

6. 7666871 - Oxazole derivatives as histamine H3 receptor agents, preparation and therapeutic uses (2010-02-23),

7. 7208505 - β3 adrenergic agonists (2007-04-24),

8. 7122680 - [object Object] (2006-10-17),

9. 7087635 - 3-substituted oxindole β3 agonists (2006-08-08),

10. 6911463 - 3-substituted oxindole β-3 agonists (2005-06-28),

11. 6881733 - Serotonergic benzofurans (2005-04-19),

12. 6825220 - 3-Substituted oxindole &bgr; 3 agonists (2004-11-30),

Title: The Innovative Contributions of Freddie Craig Stevens

Introduction

Freddie Craig Stevens is a prominent inventor based in Indianapolis, IN (US), known for his significant contributions to the field of pharmaceuticals. With a total of 11 patents to his name, Stevens has made remarkable advancements in drug development and therapeutic applications.

Latest Patents

Among his latest patents is a TARP γ8 dependent AMPA receptor antagonist, which includes a detailed formula and its pharmaceutically acceptable salts. This invention outlines its uses and methods for preparation. Another notable patent involves pyrrolidine derivatives as histamine H3 receptor antagonists. This invention discloses novel compounds that exhibit histamine-H3 receptor antagonist or inverse agonist activity, along with methods and intermediates for their preparation. Additionally, it includes pharmaceutical compositions comprising these compounds and methods for treating obesity, cognitive deficiencies, narcolepsy, and other related diseases.

Career Highlights

Freddie Craig Stevens is currently associated with Eli Lilly and Company, a leading pharmaceutical firm. His work at Eli Lilly has allowed him to focus on innovative drug solutions that address various health challenges.

Collaborations

Stevens has collaborated with notable colleagues, including Cynthia Darshini Jesudason and Daniel Jon Sall, contributing to a dynamic research environment that fosters innovation.

Conclusion

Freddie Craig Stevens exemplifies the spirit of innovation in the pharmaceutical industry through his extensive patent portfolio and collaborative efforts. His work continues to impact the field significantly, paving the way for future advancements in medicine.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…